News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jones James
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.65, valued at
$107.3
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.68, valued at
$109.2
Small acquisition of 65 shares
@ $1.72, valued at
$111.8
Small acquisition of 65 shares
@ $1.76, valued at
$114.4
Small acquisition of 65 shares
@ $1.83, valued at
$119
Small acquisition of 65 shares
@ $1.84, valued at
$119.6
Small acquisition of 23 shares
@ $1.82, valued at
$41.9
Small acquisition of 55 shares
@ $2.03, valued at
$111.7
Small acquisition of 55 shares
@ $2.12, valued at
$116.6 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 31 shares
@ $2.57, valued at
$79.7
Bought 31 shares
@ $2.52, valued at
$78.1
Bought 31 shares
@ $2.51, valued at
$77.8
Bought 31 shares
@ $2.61, valued at
$80.9
Bought 31 shares
@ $2.54, valued at
$78.7
Bought 31 shares
@ $2.61, valued at
$80.9
Bought 31 shares
@ $2.58, valued at
$80
Bought 31 shares
@ $2.65, valued at
$82.2
Bought 31 shares
@ $2.66, valued at
$82.5
Bought 31 shares
@ $2.53, valued at
$78.4
Bought 31 shares
@ $2.48, valued at
$76.9 |
|
| 09/30/2022 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 32 shares
@ $2.35, valued at
$75.2
Bought 32 shares
@ $2.31, valued at
$73.9
Bought 32 shares
@ $2.23, valued at
$71.4
Bought 32 shares
@ $2.35, valued at
$75.2
Bought 32 shares
@ $2.51, valued at
$80.3
Bought 32 shares
@ $2.59, valued at
$82.9
Bought 32 shares
@ $2.59, valued at
$82.9
Bought 32 shares
@ $2.62, valued at
$83.8
Bought 32 shares
@ $2.55, valued at
$81.6
Bought 34 shares
@ $2.44, valued at
$83
Bought 34 shares
@ $2.38, valued at
$80.9 |
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 21 shares
@ $4.14, valued at
$86.9
Bought 21 shares
@ $3.84, valued at
$80.6
Bought 21 shares
@ $4.47, valued at
$93.9
Bought 21 shares
@ $4.46, valued at
$93.7
Bought 21 shares
@ $5.61, valued at
$117.8
Bought 21 shares
@ $6.15, valued at
$129.2
Bought 21 shares
@ $5.81, valued at
$122
Bought 21 shares
@ $4.82, valued at
$101.2
Bought 30 shares
@ $4.36, valued at
$130.8
Bought 30 shares
@ $4.28, valued at
$128.4
Bought 30 shares
@ $4.29, valued at
$128.7 |
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2021 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Bought 42 shares
@ $2.69, valued at
$113
Bought 42 shares
@ $2.87, valued at
$120.5
Bought 42 shares
@ $2.82, valued at
$118.4
Bought 42 shares
@ $2.76, valued at
$115.9
Bought 42 shares
@ $2.76, valued at
$115.9
Bought 42 shares
@ $2.84, valued at
$119.3
Bought 42 shares
@ $2.73, valued at
$114.7
Bought 42 shares
@ $2.71, valued at
$113.8
Bought 42 shares
@ $2.71, valued at
$113.8
Bought 42 shares
@ $2.81, valued at
$118
Bought 42 shares
@ $2.76, valued at
$115.9 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2020 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $3.56, valued at
$3.6k
|
|
| 03/22/2019 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $5.98, valued at
$6k
|
|
| 03/23/2018 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $6.7, valued at
$6.7k
|
|
| 04/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/27/2013 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $4.78, valued at
$4.8k
|
|
| 03/19/2012 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $7.72, valued at
$7.7k
|
|
| 03/25/2011 |
4
| Jones James (Director) has filed a Form 4 on CUMBERLAND PHARMACEUTICALS INC|
Txns:
| Granted 1,000 shares
@ $0 |
|
| 06/02/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|